XNYS · Healthcare · Drug Manufacturers - General
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | 0.72 | 0.75 | +4.17% | $14.45B | ✅ Beat | +0.61% | -2.19% | — |
| 2026-02-03 | Q4 2025 | 0.56 | 0.66 | +17.86% | $17.56B | ✅ Beat | -0.60% | +7.14% | +3.26% |
| 2025-11-04 |
| Q3 2025 |
| 0.65 |
| 0.87 |
| +33.85% |
| $16.65B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-05 | Q2 2025 | 0.58 | 0.78 | +34.48% | $14.70B | ✅ Beat | — | — | — |
| 2025-04-29 | Q1 2025 | 0.67 | 0.92 | +37.31% | $13.71B | ✅ Beat | — | — | — |
| 2025-02-04 | Q4 2024 | 0.46 | 0.63 | +36.96% | $17.76B | ✅ Beat | — | — | — |
| 2024-10-29 | Q3 2024 | 0.62 | 1.06 | +70.97% | $17.70B | ✅ Beat | — | — | — |
| 2024-07-30 | Q2 2024 | 0.46 | 0.60 | +30.43% | $13.28B | ✅ Beat | — | — | — |
Showing last 8 quarters.